CERAPEDICS INC

Profile

Company Names

CERAPEDICS INC

Addresses

11025 DOVER STREET, SUITE 1600, WESTMINSTER, CO 80021

Phone Numbers

303-974-6281

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DE

Total Amount Raised:

$79,999,995.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2022-02-18 
$24,999,997.00 
$24,999,997.00 
$0.00 
Equity 
6
2018-06-26 
$21,999,998.00 
$22,000,000.00 
$2.00 
Equity 
5
2016-09-19 
$11,000,000.00 
$14,000,000.00 
$3,000,000.00 
Equity 
4
2015-02-18 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
3
2012-07-12 
$0.00 
$19,090,328.00 
$19,090,328.00 
Equity 
2
2012-02-06 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
1
2009-03-18 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEN 
 
ABRAMOWITZ 
DIRECTOR
KEN 
S. 
ABRAMOWITZ 
DIRECTOR
JEROME 
 
CONNOR 
EXECUTIVE OFFICER
LEONARD 
 
HABAS 
DIRECTOR
ANDREW 
 
HANDWERKER 
EXECUTIVE OFFICER
ANDREW 
HANDWERKER 
EXECUTIVE OFFICER
ANDREW 
J. 
HANDWERKER 
EXECUTIVE OFFICER
GLEN 
 
KASHUBA 
EXECUTIVE OFFICER, DIRECTOR
ANTONY 
 
KOBLISH 
DIRECTOR
DOUG 
 
KOHRS 
DIRECTOR
JEFF 
 
MARX 
EXECUTIVE OFFICER
JEFFREY 
G. 
MARX 
EXECUTIVE OFFICER
PAUL 
MRAZ 
DIRECTOR, EXECUTIVE OFFICER
PAUL 
J. 
MRAZ 
EXECUTIVE OFFICER, DIRECTOR
BRITT 
 
PEARSON 
EXECUTIVE OFFICER
VALESKA 
 
SCHROEDER 
DIRECTOR
JOHN 
 
TATTORY 
EXECUTIVE OFFICER
ANDREW 
TOFE 
DIRECTOR
ANDREW 
J. 
TOFE 
DIRECTOR
DREW 
 
TRIVISONNO 
EXECUTIVE OFFICER
SAMUEL 
S. 
WU 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
EASTERLY SECURITIES LLC
NONE
NONE
LEERINK PARTNERS LLC